DE69811117D1 - Tetrahydrothiopyran-phenyloxazolidinon-s-oxide - Google Patents

Tetrahydrothiopyran-phenyloxazolidinon-s-oxide

Info

Publication number
DE69811117D1
DE69811117D1 DE69811117T DE69811117T DE69811117D1 DE 69811117 D1 DE69811117 D1 DE 69811117D1 DE 69811117 T DE69811117 T DE 69811117T DE 69811117 T DE69811117 T DE 69811117T DE 69811117 D1 DE69811117 D1 DE 69811117D1
Authority
DE
Germany
Prior art keywords
phenyloxazolidinone
tetrahydrothiopyran
oxide
dichloromethyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811117T
Other languages
English (en)
Other versions
DE69811117T2 (de
Inventor
Toni-Jo Poel
P Martin
R Barbachyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69811117D1 publication Critical patent/DE69811117D1/de
Publication of DE69811117T2 publication Critical patent/DE69811117T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
DE69811117T 1997-12-05 1998-11-23 Tetrahydrothiopyran-phenyloxazolidinon-s-oxide Expired - Fee Related DE69811117T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6783097P 1997-12-05 1997-12-05
US8949898P 1998-06-16 1998-06-16
US10018598P 1998-09-14 1998-09-14
PCT/US1998/024526 WO1999029688A1 (en) 1997-12-05 1998-11-23 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones

Publications (2)

Publication Number Publication Date
DE69811117D1 true DE69811117D1 (de) 2003-03-06
DE69811117T2 DE69811117T2 (de) 2003-07-17

Family

ID=27371238

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811117T Expired - Fee Related DE69811117T2 (de) 1997-12-05 1998-11-23 Tetrahydrothiopyran-phenyloxazolidinon-s-oxide

Country Status (22)

Country Link
US (2) US6083967A (de)
EP (2) EP1254906A1 (de)
JP (1) JP2001525408A (de)
KR (1) KR20010032782A (de)
CN (2) CN1154645C (de)
AT (1) ATE231859T1 (de)
AU (2) AU752454B2 (de)
BR (1) BR9814897A (de)
CA (1) CA2309026A1 (de)
DE (1) DE69811117T2 (de)
DK (1) DK1036074T3 (de)
ES (1) ES2191985T3 (de)
HK (1) HK1032970A1 (de)
HU (1) HUP0100558A3 (de)
ID (1) ID21450A (de)
NO (1) NO316447B1 (de)
NZ (1) NZ504930A (de)
PL (1) PL340835A1 (de)
SI (1) SI1036074T1 (de)
SK (1) SK7692000A3 (de)
TW (2) TWI239331B (de)
WO (1) WO1999029688A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
MXPA00011536A (es) 1998-06-05 2002-10-17 Astrazeneca Ab Derivados de oxazolidinona, proceso para su preparacion y composiciones farmaceuticas que las contienen.
MY120189A (en) * 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AU2003259159A1 (en) 2002-08-12 2004-02-25 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
US7141570B2 (en) 2002-11-21 2006-11-28 Pharmacia & Upjohn Company N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
AU2006299126B2 (en) 2005-10-04 2012-06-28 Bayer Intellectual Property Gmbh Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CN102262066A (zh) * 2011-06-16 2011-11-30 董理 一种检测单胺氧化酶含量的方法和试剂盒
CN104610479B (zh) * 2013-11-05 2017-03-29 中国石油化工股份有限公司 用于乙烯聚合的负载化茂金属催化剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897409A (en) * 1986-09-03 1990-01-30 Delalande S.A. 5-aminoethyloxazolidin-2-one derivatives
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
KR100257418B1 (ko) * 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논
CA2147753C (en) * 1992-12-08 2004-08-03 Michael Robert Barbachyn Tropone-substituted phenyloxazolidinone antibacterial agents
BR9610474A (pt) * 1995-09-01 1999-03-02 Upjohn Co Feniloxazolidinonas tendo uma ligação c-c a anéis heterocíclicos com 4-8 membros
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
SI1036074T1 (en) 2003-08-31
DE69811117T2 (de) 2003-07-17
ATE231859T1 (de) 2003-02-15
NO316447B1 (no) 2004-01-26
CN1278817A (zh) 2001-01-03
AU1796899A (en) 1999-06-28
US6083967A (en) 2000-07-04
HK1032970A1 (en) 2001-08-10
HUP0100558A3 (en) 2002-08-28
EP1254906A1 (de) 2002-11-06
BR9814897A (pt) 2000-10-03
WO1999029688A1 (en) 1999-06-17
NO20002834L (no) 2000-07-21
CN1154645C (zh) 2004-06-23
EP1036074B1 (de) 2003-01-29
HUP0100558A2 (hu) 2002-05-29
PL340835A1 (en) 2001-02-26
TW553942B (en) 2003-09-21
ES2191985T3 (es) 2003-09-16
CA2309026A1 (en) 1999-06-17
NZ504930A (en) 2002-05-31
US6265178B1 (en) 2001-07-24
TWI239331B (en) 2005-09-11
CN1532535A (zh) 2004-09-29
AU2002301031B2 (en) 2005-08-25
KR20010032782A (ko) 2001-04-25
NO20002834D0 (no) 2000-06-02
JP2001525408A (ja) 2001-12-11
DK1036074T3 (da) 2003-06-23
TW200307673A (en) 2003-12-16
ID21450A (id) 1999-06-10
AU752454B2 (en) 2002-09-19
EP1036074A1 (de) 2000-09-20
SK7692000A3 (en) 2001-03-12

Similar Documents

Publication Publication Date Title
DE69811117T2 (de) Tetrahydrothiopyran-phenyloxazolidinon-s-oxide
NO953305L (no) Antranilsyrederivat
ES2182234T3 (es) Inhibidores de metaloproteasa.
PT918776E (pt) Sintese total de acilfulvenos antitumorais
ATE183189T1 (de) Antifungale sordaridinderivate
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
BR0115996A (pt) Sulfamidotienopirimidinas
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
DK0841327T3 (da) Triazolantisvampemiddel
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
BR9902096A (pt) Pitazóis.
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
DK1140932T3 (da) Derivater af benzo-1,8-naphtyridin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee